Division of Rheumatology, Department of Medicine, Chris Hani Baragwanath Hospital, University of the Witwatersrand, Johannesburg, South Africa.
Scand J Rheumatol. 2012 Oct;41(5):366-74. doi: 10.3109/03009742.2012.676065. Epub 2012 Jul 18.
The severity and predictors of functional disability and health-related quality of life (HRQoL) in a cohort of South Africans with early rheumatoid arthritis (RA) were investigated.
Changes in the Health Assessment Questionnaire Disability Index (HAQ) and the 36-Item Short Form Health Survey (SF-36) following 12 months of traditional disease-modifying anti-rheumatic drugs (DMARDs) were studied in previously DMARD-naïve adults with disease duration ≤ 2 years.
The majority of the 171 patients were female (82%), Black Africans (89%) with a mean (SD) symptom duration of 11.6 (7.0) months. In the 134 patients seen at 12 months, there were significant improvements in the HAQ and all domains of the SF-36 but 92 (69%) still had substantial functional disability (HAQ > 0.5) and 89 (66%) had suboptimal mental health [SF-36 mental composite score (MCS) < 66.6]. Multivariate analysis showed that female sex (p = 0.05) and high baseline HAQ score (p < 0.01) predicted substantial functional disability at 12 months. Unemployment (p = 0.03), high baseline pain (p = 0.02), and HAQ score (p = 0.04) predicted suboptimal mental health, with a trend towards a low level of schooling being significant (p = 0.08).
Early RA has a broad impact on HRQoL in indigent South Africans, with a large proportion of patients still showing substantial functional disability and suboptimal mental health despite 12 months of DMARD therapy. Further research is needed to establish the role of interventions including psychosocial support, rehabilitation programmes, and biological therapy to improve physical function and HRQoL in this population.
本研究旨在调查南非早期类风湿关节炎(RA)患者队列的功能障碍严重程度及其预测因素,以及健康相关生活质量(HRQoL)。
在未经传统疾病修饰抗风湿药物(DMARDs)治疗的患者中,研究了病程≤2 年的新诊断为 RA 且此前未使用过 DMARDs 的成年患者在接受 12 个月 DMARDs 治疗后的健康评估问卷残疾指数(HAQ)和 36 项简短健康调查(SF-36)的变化。
171 例患者中大多数为女性(82%),黑人(89%),平均(SD)病程为 11.6(7.0)个月。在 12 个月时观察到的 134 例患者中,HAQ 和 SF-36 的所有领域均有显著改善,但仍有 92 例(69%)存在严重的功能障碍(HAQ>0.5),89 例(66%)心理健康不佳[SF-36 心理综合评分(MCS)<66.6]。多变量分析显示,女性(p=0.05)和基线时高 HAQ 评分(p<0.01)预测 12 个月时严重的功能障碍。失业(p=0.03)、基线时疼痛程度高(p=0.02)和 HAQ 评分(p=0.04)预测心理健康不佳,而受教育程度低呈显著趋势(p=0.08)。
在贫困的南非人群中,早期 RA 对 HRQoL 有广泛的影响,尽管接受了 12 个月的 DMARD 治疗,但仍有很大比例的患者存在严重的功能障碍和心理健康不佳。需要进一步研究以确定包括心理社会支持、康复计划和生物治疗等干预措施在改善该人群的身体功能和 HRQoL 方面的作用。